Next Generation Therapies

Sarah H. Lisanby, M.D., Duke University School of Medicine
Sarah H. Lisanby, M.D.
November 15, 2011

A significant minority of people with depressive illness fail to respond to any currently available antidepressant medication. However, new methods of brain stimulation offer the possibility of relief from their symptoms...

Alexander Neumeister, M.D.
Alexander Neumeister, M.D.
November 09, 2011

A team led by NARSAD Independent Investigator Grantee Alexander Neumeister, M.D., has provided evidence of dysfunction in a key brain system linked with the occurrence of PTSD. This new discovery holds promise as a target...

John S. March, MD, MPH
John S. March, MD, MPH
October 19, 2011

A recent 12-week study conducted by a team including John S. March, MD, MPH and Scott Compton, PhD indicates that cognitive behavioral therapy, in addition to medication, significantly improves the symptoms of OCD in...

Carlos A. Zarate, M.D.
Carlos A. Zarate, M.D.
October 10, 2011

Carlos A. Zarate, M.D., 2011 Outstanding Achievement in Mood Disorders Research Prizewinner, has pioneered research on rapid-acting antidepressants and their mechanism of action. One such drug is ketamine, which has been...

Aaron T. Beck, M.D.
Aaron T. Beck, M.D.
October 06, 2011

Dr. Aaron T. Beck, Foundation Distinguished Investigator, invented cognitive behavioral therapy decades ago and now demonstrates that it can successfully treat the ‘negative’ symptoms of schizophrenia, such as emotional...

Pages

Subscribe to